Cover Image

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.

Bibliographic Details
Corporate Authors:	United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O. : 2002.
Series:	U.S. Congressional Hearings.
Subjects:	United States. > Drug Price Competition and Patent Term Restoration Act of 1984. Prescription pricing > Law and legislation > United States. Drugs > United States > Patents. Generic drugs > United States. Patent extensions > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.
Published: (2002)

"Skinny labels" for generic drugs under Hatch-Waxman /
by: Hickey, Kevin J.
Published: (2024)

The Hatch-Waxman Act : a primer /
by: Thomas, John R., 1967-
Published: (2019)

Hatch-Waxman Act : Legislative Changes Affecting Pharmaceutical Patents.
Published: (2004)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2003)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2002)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2003)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2003)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2003)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2003)

Hatch-Waxman Act : Proposed Legislative Changes.
Published: (2002)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2003)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2003)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2004)

Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Published: (2003)

Hatch-Waxman Act : Legislative Changes in the 108th Congress Affecting Pharmaceutical Patents.
Published: (2004)

Prescription drugs : many factors affected FDA's approval of selected "pipeline" drugs : report to congressional requesters.
Published: (2000)

"Hatch-Waxman" Act : Selected Patent-Related Issues.
Published: (2002)

Hatch-Waxman Act : Proposed Legislative Changes.
Published: (2002)

Patent infringement and experimental use under the Hatch-Waxman Act : current issues /
by: Thomas, John R., 1967-
Published: (2019)

Generic drug entry prior to patent expiration : an FTC study /
Published: (2002)

Hatch-Waxman Related Provisions of the Medicare Prescription Drug Bills (H.R. 1 and S. 1) : A Side-by-Side Comparison.
Published: (2003)

Closing the coverage gap : Medicare prescription drugs are becoming more affordable.
Published: (2015)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)

Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003 /
by: Stagnitti, Marie N.
Published: (2006)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Generic Animal Drug and Patent Term Restoration Act : hearing before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, second session on H.R. 4982 ... September 14, 1988.
Published: (1989)

Examining the root causes of drug shortages : challenges in pharmaceutical drug supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, May 11, 2023.
Published: (2024)

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
Published: (2002)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)

Generic drugs : stakeholders views on improving FDA's information on patents : report to congressional committees /
Published: (2023)

Patent term extension and pharmaceutical innovation : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, second session, February 4, 1982.
Published: (1983)

Protecting Consumer Access to Generic Drugs Act of 2007 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 1902, May 2, 2007.
Published: (2007)

H.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 31 2009.
Published: (2012)

Protecting Consumer Access to Generic Drugs Act of 2007 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 1902, May 2, 2007.
Published: (2007)

Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office).
Published: (2020)